Barberà del Vallès, Spain

Rosa Maria Espinosa Ferrer

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Esteve Quimica S.a.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rosa Maria Espinosa Ferrer. Retrieved from https://idiyas.com/inventor/rosa-maria-espinosa-ferrer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rosa Maria Espinosa Ferrer: Innovator in Pharmaceutical Chemistry

Introduction

Rosa Maria Espinosa Ferrer is a notable inventor based in Barberà del Vallès, Spain. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of solid forms of dabigatran etexilate mesylate.

Latest Patents

Rosa holds a patent for "Solid forms of dabigatran etexilate mesylate and processes for their preparation." This patent focuses on solid forms of dabigatran etexilate mesylate, specifically crystalline Form A and amorphous forms. It also details processes for their preparation and pharmaceutical compositions that include these forms. Additionally, her patent encompasses a crystalline form of dabigatran etexilate base (Form A) and the process for its preparation.

Career Highlights

Rosa is currently employed at Esteve Química, S.A., where she applies her expertise in pharmaceutical development. Her work has been instrumental in advancing the understanding and application of dabigatran etexilate mesylate in medical treatments.

Collaborations

Rosa has collaborated with notable colleagues, including Martí Bartra Sanmartí and Maria Del Pilar Lupon Roses. These partnerships have contributed to her innovative work in the pharmaceutical sector.

Conclusion

Rosa Maria Espinosa Ferrer exemplifies the impact of innovation in pharmaceutical chemistry through her patent and collaborative efforts. Her contributions continue to influence the field and enhance medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…